MSIMEP: Predicting microsatellite instability from microarray DNA methylation tumor profiles iScience
Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study TRANSPL CELL THER
Effect of CD34+Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide TRANSPL CELL THER
Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome EPIGENETICS-US
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes J Clin Oncol
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry FRONT IMMUNOL
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study LEUKEMIA LYMPHOMA
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study LANCET HAEMATOL
β-Catenin activity induces an RNA biosynthesis program promoting therapy resistance in T-cell acute lymphoblastic leukemia EMBO MOL MED